Acute myocardial infarction and transient elevated anticardiolipin antibody in a young adult with possible familial hypercholesterolemia: a case report : Anticardiolipin antibody and myocardial infarction
- PMID: 31248367
- PMCID: PMC6598355
- DOI: 10.1186/s12872-019-1135-y
Acute myocardial infarction and transient elevated anticardiolipin antibody in a young adult with possible familial hypercholesterolemia: a case report : Anticardiolipin antibody and myocardial infarction
Abstract
Background: Familial hypercholesterolemia (FH) can lead to premature coronary heart disease. Anticardiolipin antibody may be a contributor for thrombosis. Here, we report an adult with possible FH suffered from premature myocardial infarction that may be triggered by transient increased anticardiolipin antibody.
Case presentation: A 29-year-old male had presented with a history of 2-h chest pain and numbness of left upper arm before 5 days. The electrocardiogram (ECG) had demonstrated inferior wall myocardial infarction (MI). Five days later he was admitted to our hospital and diagnosed as acute MI and possible FH (premature coronary heart disease, low density lipoprotein cholesterol of 5.90 mmol/L) with increased anticardiolipin antibody (up to 120 RU/ml). Other auto-antibodies including β2-glicoprotein antibodies IgM, IgA, IgG, lupus anticoagulant (LA), antinuclear antibodies, anti-myocardial antibody were normal. Coronary artery angiography (CAG) showed right coronary artery was total occlusion from the middle segment. Then he underwent percutaneous coronary intervention with a stent. Four days later, he was discharged with complete recovery. CAG showed intra-stent restenosis and anticardiolipin antibody level was normal and the patient had no any symptoms at 6-month follow-up.
Conclusions: Transient elevated anticardiolipin antibody may be a trigger or biomarker of cardiac thrombotic events in younger atherosclerotic patients.
Keywords: Anticardiolipin antibody; Familial hypercholesterolemia; Myocardial infarction; Thrombosis.
Conflict of interest statement
The authors have no any conflicts of interests to disclose.
Figures




Similar articles
-
Acute myocardial infarction in a patient positive for lupus anticoagulant: a case report.BMC Cardiovasc Disord. 2019 Jul 12;19(1):167. doi: 10.1186/s12872-019-1153-9. BMC Cardiovasc Disord. 2019. PMID: 31299896 Free PMC article.
-
Thrombocytosis and coronary occlusion.JACC Cardiovasc Interv. 2012 Jun;5(6):e18-9. doi: 10.1016/j.jcin.2011.12.018. JACC Cardiovasc Interv. 2012. PMID: 22721672 No abstract available.
-
Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes.JACC Cardiovasc Interv. 2013 Jan;6(1):36-43. doi: 10.1016/j.jcin.2012.08.018. Epub 2012 Dec 19. JACC Cardiovasc Interv. 2013. PMID: 23266233
-
Successful trapping of an organized thrombus in a coronary artery aneurysm in myocardial infarction: case report and literature review.Cardiovasc Revasc Med. 2008 Jan-Mar;9(1):52-5. doi: 10.1016/j.carrev.2007.08.006. Cardiovasc Revasc Med. 2008. PMID: 18206639 Review.
-
The Ideal Anticoagulation Strategy in ST-Elevation Myocardial Infarction.Prog Cardiovasc Dis. 2015 Nov-Dec;58(3):247-59. doi: 10.1016/j.pcad.2015.08.007. Epub 2015 Aug 7. Prog Cardiovasc Dis. 2015. PMID: 26260610 Review.
Cited by
-
Diagnostic efficacy of ACA, aβ2-GP1, hs-CRP, and Hcy for cerebral infarction and their relationship with the disease severity.Am J Transl Res. 2024 Jun 15;16(6):2369-2378. doi: 10.62347/DDWQ9504. eCollection 2024. Am J Transl Res. 2024. PMID: 39006294 Free PMC article.
-
The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.BMC Cardiovasc Disord. 2020 Dec 4;20(1):510. doi: 10.1186/s12872-020-01798-2. BMC Cardiovasc Disord. 2020. PMID: 33276720 Free PMC article.
References
-
- Trzeciak P, Gierlotka M, Gasior M, Osadnik T, Hawranek M, Lekston A, Zembala M, Polonski L. In-hospital and 12-month outcomes after acute coronary syndrome treatment in patients aged<40 years of age (from the polish registry of acute coronary syndromes) Am J Cardiol. 2014;114(2):175–180. doi: 10.1016/j.amjcard.2014.04.024. - DOI - PubMed
-
- Puricel S, Lehner C, Oberhansli M, Rutz T, Togni M, Stadelmann M, Moschovitis A, Meier B, Wenaweser P, Windecker S, et al. Acute coronary syndrome in patients younger than 30 years--aetiologies, baseline characteristics and long-term clinical outcome. Swiss Med Wkly. 2013;143:w13816. - PubMed
-
- Hosseini SK, Soleimani A, Karimi AA, Sadeghian S, Darabian S, Abbasi SH, Ahmadi SH, Zoroufian A, Mahmoodian M, Abbasi A. Clinical features, management and in-hospital outcome of ST elevation myocardial infarction (STEMI) in young adults under 40 years of age. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace. 2009;72(2):71–76. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous